Shoraan B. Saaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shoraan B. Saaya has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alexander A. Gostev
Meshalkin National Medical Research Center
17 shared publications - Alexey V. Cheban
Meshalkin National Medical Research Center Novosibirsk Russian Federation
16 shared publications - Pavel V. Ignatenko
Meshalkin National Medical Research Center
14 shared publications - Olesia S. Osipova
National Medical Research Center named after Academician E.N. Meshalkin, Ministry of Health of the Russian Federation, 630055, Novosibirsk, Russian Federation
12 shared publications - Andrey A. Karpenko
Meshalkin National Medical Research Center
10 shared publications - Artem A. Rabtsun
Meshalkin National Medical Research Center
10 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by South Ural State Medical University in Continuing Medical Education and Science
- Vol. 21 (2) , 3-10
Two-year results of endovascular and hybrid treatment of ilio-femoral artery segment
Background. This pilot randomized study will provide insight into the feasibility of endovascular and hybrid treatment for patients with combined iliac and femoral artery pathology. The aim of this pilot randomized study was to compare the two-year safety and efficacy of endovascular treatment (EVT) versus hybrid repair (HR) using an interwoven nitinol stent in patients with combined occlusive lesions of the iliac and common femoral arteries. Materials and methods. In the EVT group, after recanalization and balloon angioplasty of the iliac and common femoral arteries, it was implanted interwoven nitinol stents. In the HR group, patients underwent recanalization and stenting of the iliac arteries, as in the EVT group, but additionally underwent common femoral artery endarterectomy with xenopericardial patch angioplasty. Results. A total of 62 patients were randomized (31 in the EVT group and 31 in the HR group). Mean length of hospital stay was shorter in the EVT group (p = 0.001). There were no deaths or major adverse cardiovascular events (MACE) within 30 days after surgery in either group. The 30-day perioperative complication rate was 9.7% in the EVT group versus 22.6% in the HR group (p = 0.17). Primary patency at 12 and 24 months was 81% and 60% in the EVT group, and 94% and 80% in the HR group (p = 0.12, p = 0.09). Secondary patency at 24 months was 90% in the EVT group versus 97% in the HT group (p = 0.27). Conclusions. This pilot study confirms that EVT and HR are comparable in terms of safety, although EVT shows a trend toward lower primary patency after 24 months of follow-up. A larger study is needed to confirm these findings.
- 23 July 2026
- Published by South Ural State Medical University in Continuing Medical Education and Science
- Vol. 21 (2) , 3-10
Open AccessTwo-year results of endovascular and hybrid treatment of ilio-femoral artery segment
Background. This pilot randomized study will provide insight into the feasibility of endovascular and hybrid treatment for patients with combined iliac and femoral artery pathology. The aim of this pilot randomized study was to compare the two-year safety and efficacy of endovascular treatment (EVT) versus hybrid repair (HR) using an interwoven nitinol stent in patients with combined occlusive lesions of the iliac and common femoral arteries. Materials and methods. In the EVT group, after recanalization and balloon angioplasty of the iliac and common femoral arteries, it was implanted interwoven nitinol stents. In the HR group, patients underwent recanalization and stenting of the iliac arteries, as in the EVT group, but additionally underwent common femoral artery endarterectomy with xenopericardial patch angioplasty. Results. A total of 62 patients were randomized (31 in the EVT group and 31 in the HR group). Mean length of hospital stay was shorter in the EVT group (p = 0.001). There were no deaths or major adverse cardiovascular events (MACE) within 30 days after surgery in either group. The 30-day perioperative complication rate was 9.7% in the EVT group versus 22.6% in the HR group (p = 0.17). Primary patency at 12 and 24 months was 81% and 60% in the EVT group, and 94% and 80% in the HR group (p = 0.12, p = 0.09). Secondary patency at 24 months was 90% in the EVT group versus 97% in the HT group (p = 0.27). Conclusions. This pilot study confirms that EVT and HR are comparable in terms of safety, although EVT shows a trend toward lower primary patency after 24 months of follow-up. A larger study is needed to confirm these findings.
- Open Access
- 14 April 2026
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 30 (1) , 78-89
Long-term results of treatment of ilio-femoral segment by hybrid and endovascular methodsby hybrid and endovascular methods
Introduction. The significance of this study lies in its lack of clear guidelines for the selection of surgical treatment options for patients with iliofemoral occlusive disease. Objective. The objective of this study was to evaluate the longterm outcomes of endovascular and hybrid interventions for the treatment of occlusive lesions in the iliofemoral artery segment. Methods. A total of 62 patients were randomized (n = 31 in the endovascular treatment (EVT) group, n = 31 in the hybrid treatment (HT) group). In the EVT group, an interwoven nitinol stents were implanted in patients after recanalization and balloon angioplasty of the iliac and common femoral arteries. In the HR group, patients underwent endarterectomy from the common femoral artery with xenopericardial patch repair, recanalization and stenting of the iliac arteries with using an interwoven nitinol stent. The follow-up period was 3 years. Results. Thirty-day complications occurred in 3 (9.7 %) of the EVT group and 7 (22.6 %) of the HT group. The primary patency rate after 36 months was 60 % in the EVT group and 80 % in the HT group. Secondary patency rates at 36 months were 83 % and 87 %, respectively. Survival and limb preservation rates did not differ significantly between the groups at 36-month follow-up. Conclusion. This study supports the use of hybrid treatment over endovascular stenting, as it provides greater safety and primary patency during a three-year follow-up period.
- 14 April 2026
- Published by Meshalkin National Medical Research Center in Patologiya krovoobrashcheniya i kardiokhirurgiya
- Vol. 30 (1) , 78-89
Open AccessLong-term results of treatment of ilio-femoral segment by hybrid and endovascular methodsby hybrid and endovascular methods
Introduction. The significance of this study lies in its lack of clear guidelines for the selection of surgical treatment options for patients with iliofemoral occlusive disease. Objective. The objective of this study was to evaluate the longterm outcomes of endovascular and hybrid interventions for the treatment of occlusive lesions in the iliofemoral artery segment. Methods. A total of 62 patients were randomized (n = 31 in the endovascular treatment (EVT) group, n = 31 in the hybrid treatment (HT) group). In the EVT group, an interwoven nitinol stents were implanted in patients after recanalization and balloon angioplasty of the iliac and common femoral arteries. In the HR group, patients underwent endarterectomy from the common femoral artery with xenopericardial patch repair, recanalization and stenting of the iliac arteries with using an interwoven nitinol stent. The follow-up period was 3 years. Results. Thirty-day complications occurred in 3 (9.7 %) of the EVT group and 7 (22.6 %) of the HT group. The primary patency rate after 36 months was 60 % in the EVT group and 80 % in the HT group. Secondary patency rates at 36 months were 83 % and 87 %, respectively. Survival and limb preservation rates did not differ significantly between the groups at 36-month follow-up. Conclusion. This study supports the use of hybrid treatment over endovascular stenting, as it provides greater safety and primary patency during a three-year follow-up period.
- 4 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (5) , 603-616
Interwoven Nitinol Stent Versus Laser-Cut-Type Nitinol Stent for Long Femoropopliteal Occlusive Disease: A Propensity Matched Analysis
Purpose There are still limited data to determine the efficacy of interwoven nitinol stent (INS) compared with laser-cut nitinol stent (CNS) for the endovascular treatment of long femoropopliteal lesions. The aim of this study is to evaluate the short- and mid-term results of the effectiveness of CNS and INS in the revascularization of long femoropopliteal occlusions. We performed analyses of the primary and secondary outcome measures for subgroups of patients with below-the-knee and “above-the-knee” lesions. Materials and Methods A retrospective propensity matched analysis was conducted on symptomatic patients (Rutherford category 3–6) with long occlusions of the femoropopliteal segment (> 15 cm) who underwent stenting with either INS or CNS from 2012 to 2020. The primary outcome measure was the primary patency in 2 years. Secondary outcome measures were secondary patency, major adverse cardiovascular events, major adverse limb events, sustained clinical improvement, and mortality. Results After propensity score matching, 126 and 125 patients remained in the INS and CNS groups, respectively. There were no cases of major cardiovascular events (MACE) or major limb events in both groups during the perioperative period. There were no significant differences in primary and secondary patency during a 2-year follow-up. There were no stent fractures in the INS group, whereas in the CNS group the stent fractures rate reached 37 (29.6%) patients (p < 0.001). In the “above-the-knee” subgroup, INS and CNS showed comparable primary patency rates. However, the secondary patency rates were 82.0% and 96.9% in INS and CNS groups, respectively (p < 0.001). The secondary sustained clinical improvement rates were 79.8% and 93.9% in INS and CNS subgroups, respectively (p < 0.001). In the “below-the-knee subgroup,” INS showed higher primary patency rate (INS: 64.9% CNS: 37.1%; p = 0.04). In the CNS group, the fractures rate “below the knee” was statistically significantly higher compared with stents “above the knee” (p = 0.03). Conclusion After propensity score matching, INS showed comparable results with CNS for the whole cohort. However, INS seems to achieve better outcomes for femoropopliteal lesion extended to the below-the-knee level. Graphical Abstract
- 4 March 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 48 (5) , 603-616
Interwoven Nitinol Stent Versus Laser-Cut-Type Nitinol Stent for Long Femoropopliteal Occlusive Disease: A Propensity Matched Analysis
Purpose There are still limited data to determine the efficacy of interwoven nitinol stent (INS) compared with laser-cut nitinol stent (CNS) for the endovascular treatment of long femoropopliteal lesions. The aim of this study is to evaluate the short- and mid-term results of the effectiveness of CNS and INS in the revascularization of long femoropopliteal occlusions. We performed analyses of the primary and secondary outcome measures for subgroups of patients with below-the-knee and “above-the-knee” lesions. Materials and Methods A retrospective propensity matched analysis was conducted on symptomatic patients (Rutherford category 3–6) with long occlusions of the femoropopliteal segment (> 15 cm) who underwent stenting with either INS or CNS from 2012 to 2020. The primary outcome measure was the primary patency in 2 years. Secondary outcome measures were secondary patency, major adverse cardiovascular events, major adverse limb events, sustained clinical improvement, and mortality. Results After propensity score matching, 126 and 125 patients remained in the INS and CNS groups, respectively. There were no cases of major cardiovascular events (MACE) or major limb events in both groups during the perioperative period. There were no significant differences in primary and secondary patency during a 2-year follow-up. There were no stent fractures in the INS group, whereas in the CNS group the stent fractures rate reached 37 (29.6%) patients (p < 0.001). In the “above-the-knee” subgroup, INS and CNS showed comparable primary patency rates. However, the secondary patency rates were 82.0% and 96.9% in INS and CNS groups, respectively (p < 0.001). The secondary sustained clinical improvement rates were 79.8% and 93.9% in INS and CNS subgroups, respectively (p < 0.001). In the “below-the-knee subgroup,” INS showed higher primary patency rate (INS: 64.9% CNS: 37.1%; p = 0.04). In the CNS group, the fractures rate “below the knee” was statistically significantly higher compared with stents “above the knee” (p = 0.03). Conclusion After propensity score matching, INS showed comparable results with CNS for the whole cohort. However, INS seems to achieve better outcomes for femoropopliteal lesion extended to the below-the-knee level. Graphical Abstract
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (4)
Comparative analysis of endovascular and open surgical treatment of aortoiliac bifurcation lesions
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (4)
Comparative analysis of endovascular and open surgical treatment of aortoiliac bifurcation lesions
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (3) , 102-110
Endovascular versus hybrid interventions for steno-occlusive lesions of the iliofemoral segment (a pilot prospective randomized trial)
Эндоваскулярные и гибридные вмешательства при стено-окклюзионных поражениях подвздошно-бедренного сегмента (пилотное проспективное рандомизированное
- 1 January 2025
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 31 (3) , 102-110
Endovascular versus hybrid interventions for steno-occlusive lesions of the iliofemoral segment (a pilot prospective randomized trial)
Эндоваскулярные и гибридные вмешательства при стено-окклюзионных поражениях подвздошно-бедренного сегмента (пилотное проспективное рандомизированное
- 1 January 2024
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 30 (3)
Effectiveness of laser-cut and interwoven nitinol stents in the revascularization of long femoropopliteal occlusions. Early and mid-term results
Эффективность реваскуляризации длинных бедренно-подколенных окклюзий при использовании резаных и плетеных нитиноловых стентов. Ранние и среднесрочные
- 1 January 2024
- Published by Geotar-Media Publishing Group in Angiology and vascular surgery
- Vol. 30 (3)
Effectiveness of laser-cut and interwoven nitinol stents in the revascularization of long femoropopliteal occlusions. Early and mid-term results
Эффективность реваскуляризации длинных бедренно-подколенных окклюзий при использовании резаных и плетеных нитиноловых стентов. Ранние и среднесрочные
- Open Access
- 6 July 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (7) , 3183
Chronic mesenteric ischemia: causes, methods of diagnosis and treatment
Chronic mesenteric ischemia (CMI) is an urgent public health problem. The long asymptomatic course of the disease, sudden onset and an unfavorable prognosis in the absence of treatment make it necessary to pay closer attention to this pathology. There are currently two competitive treatments for CMI: surgical and endovascular revascularization. Despite numerous studies comparing these methods, the question of which one is more effective and reliable remains open. The review includes current data from clinical trials and meta-analyses demonstrating the advantages and disadvantages of both methods.
- 6 July 2022
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 21 (7) , 3183
Open AccessChronic mesenteric ischemia: causes, methods of diagnosis and treatment
Chronic mesenteric ischemia (CMI) is an urgent public health problem. The long asymptomatic course of the disease, sudden onset and an unfavorable prognosis in the absence of treatment make it necessary to pay closer attention to this pathology. There are currently two competitive treatments for CMI: surgical and endovascular revascularization. Despite numerous studies comparing these methods, the question of which one is more effective and reliable remains open. The review includes current data from clinical trials and meta-analyses demonstrating the advantages and disadvantages of both methods.
- 17 May 2022
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (7) , 929-938
Bypass Versus Interwoven Nitinol Stents for Long Femoro-Popliteal Occlusions: A Propensity Matched Analysis
Purpose To compare femoro-popliteal bypass and interwoven nitinol stenting for long occlusions of the femoro-popliteal segment. Materials and Methods Single center retrospective propensity matching analysis of the symptomatic patients with long occlusion of the femoro-popliteal segment (> 20 cm), who underwent stenting with interwoven nitinol stent or femoro-popliteal bypass from 2012 to 2020. Primary endpoints: primary patency, primary-assisted patency, secondary patency. Secondary endpoints: major adverse cardiovascular events, major adverse limb events, primary sustained clinical improvement, survival. Results A total of 437 patients were enrolled: 294 in the bypass group and 143 in the endovascular therapy (EVT) group. After propensity score matching, 264 and 113 patients remained in the groups, respectively. A median occlusion length was 250 mm. One-year and two-year primary and secondary patency rates were comparable in both groups (two-year primary patency: 68.5% for bypass vs. 68.9% for EVT, p = 1.00). In the “above the knee” subgroup analysis, two-year secondary patency was higher in the EVT group than in the bypass group (90.9% vs. 77.5%, p = 0.048). In “below-the-knee” subgroup analysis, primary and primary assisted patency were statistically significantly higher in the EVT group than in artificial bypass subgroup (66.7% vs. 42.4%, p = .046 and 76.7% vs. 45.5%, p = .011, respectively). However, compared to autovenous bypass, the EVT group showed lower primary patency rates, although the differences are not significant. Conclusion A nonselective endovascular strategy can allow for regular successful treatment of femoro-popliteal lesions longer than 25 cm.
- 17 May 2022
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (7) , 929-938
Bypass Versus Interwoven Nitinol Stents for Long Femoro-Popliteal Occlusions: A Propensity Matched Analysis
Purpose To compare femoro-popliteal bypass and interwoven nitinol stenting for long occlusions of the femoro-popliteal segment. Materials and Methods Single center retrospective propensity matching analysis of the symptomatic patients with long occlusion of the femoro-popliteal segment (> 20 cm), who underwent stenting with interwoven nitinol stent or femoro-popliteal bypass from 2012 to 2020. Primary endpoints: primary patency, primary-assisted patency, secondary patency. Secondary endpoints: major adverse cardiovascular events, major adverse limb events, primary sustained clinical improvement, survival. Results A total of 437 patients were enrolled: 294 in the bypass group and 143 in the endovascular therapy (EVT) group. After propensity score matching, 264 and 113 patients remained in the groups, respectively. A median occlusion length was 250 mm. One-year and two-year primary and secondary patency rates were comparable in both groups (two-year primary patency: 68.5% for bypass vs. 68.9% for EVT, p = 1.00). In the “above the knee” subgroup analysis, two-year secondary patency was higher in the EVT group than in the bypass group (90.9% vs. 77.5%, p = 0.048). In “below-the-knee” subgroup analysis, primary and primary assisted patency were statistically significantly higher in the EVT group than in artificial bypass subgroup (66.7% vs. 42.4%, p = .046 and 76.7% vs. 45.5%, p = .011, respectively). However, compared to autovenous bypass, the EVT group showed lower primary patency rates, although the differences are not significant. Conclusion A nonselective endovascular strategy can allow for regular successful treatment of femoro-popliteal lesions longer than 25 cm.
- Open Access
Impact of shaggy aorta on intraoperative cerebral embolism during carotid artery stenting
Background Careful selection of patients for carotid stenting is necessary. We suggest that patients with a shaggy aorta syndrome may have a higher risk of perioperative embolic complications. Methods The study is a subanalysis of the SIBERIA Trial. We included 72 patients undergoing transfemoral carotid artery stenting. All patients had an MRI DWI and a clinical neurological examination two days before and on the second and 30th days after the intervention. Results 46 patients had shaggy aorta syndrome. Intraoperative embolisms were recorded in 82.6% and 46.1% of patients with and without shaggy aorta syndrome, respectively (p=0.001). New asymptomatic ischemic brain lesions in the postoperative period occurred in 78.3% and in 26.9% of patients with and without shaggy aorta syndrome, respectively (p=0.000). 3 (6.5%) cases of stroke within 30 days after the procedure were observed only in patients with shaggy aorta syndrome. Shaggy aorta syndrome (OR 5.54 [1.83:16.7], p=0.001) and aortic arch ulceration (OR 6.67 [1.19: 37.3], p = 0.02) were independently associated with cerebral embolism. Shaggy aorta syndrome (OR 9.77 [3.14-30.37], p=0.000) and aortic arch ulceration (OR 12.9 [2.3: 72.8], p = 0.003) were independently associated with ipsilateral new asymptomatic ischemic brain lesions. Conclusions Shaggy aorta syndrome and aortic arch ulceration significantly increase the odds of intraoperative embolism and new asymptomatic ischemic brain lesions. Carotid endarterectomy or transcervical carotid stent should be selected in the presence of aortic ulceration.
Open AccessImpact of shaggy aorta on intraoperative cerebral embolism during carotid artery stenting
Background Careful selection of patients for carotid stenting is necessary. We suggest that patients with a shaggy aorta syndrome may have a higher risk of perioperative embolic complications. Methods The study is a subanalysis of the SIBERIA Trial. We included 72 patients undergoing transfemoral carotid artery stenting. All patients had an MRI DWI and a clinical neurological examination two days before and on the second and 30th days after the intervention. Results 46 patients had shaggy aorta syndrome. Intraoperative embolisms were recorded in 82.6% and 46.1% of patients with and without shaggy aorta syndrome, respectively (p=0.001). New asymptomatic ischemic brain lesions in the postoperative period occurred in 78.3% and in 26.9% of patients with and without shaggy aorta syndrome, respectively (p=0.000). 3 (6.5%) cases of stroke within 30 days after the procedure were observed only in patients with shaggy aorta syndrome. Shaggy aorta syndrome (OR 5.54 [1.83:16.7], p=0.001) and aortic arch ulceration (OR 6.67 [1.19: 37.3], p = 0.02) were independently associated with cerebral embolism. Shaggy aorta syndrome (OR 9.77 [3.14-30.37], p=0.000) and aortic arch ulceration (OR 12.9 [2.3: 72.8], p = 0.003) were independently associated with ipsilateral new asymptomatic ischemic brain lesions. Conclusions Shaggy aorta syndrome and aortic arch ulceration significantly increase the odds of intraoperative embolism and new asymptomatic ischemic brain lesions. Carotid endarterectomy or transcervical carotid stent should be selected in the presence of aortic ulceration.
- Open Access
- 7 April 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 37 (1) , 96-107
Comparative retrospective analysis of the results of open femoral-popliteal bypass grafting and endovascular stenting with an interwoven biomimetic stent in patients with prolonged occlusions of the arteries in the femoropopliteal segment
Introduction. Autovenous graft is considered the gold standard for prolonged occlusive lesions of the arteries in the femoralpopliteal segment. However, the vein is not always anatomically suitable for bypass grafting; it may have been previously used in previous operations, for example, in coronary artery bypass grafting. Open surgery is always more traumatic than endovascular surgery. Conventional nitinol stents show unsatisfactory results in the femoral-popliteal position due to the high percentage of reocclusions associated with their breakage during physiological movements in the leg joints. The modified method of making interwoven nitinol stents allows improving their biomimetic properties and reducing the percentage of breakages and, accordingly, reocclusions.Material and Methods. There was a retrospective analysis of 437 patients with prolonged atherosclerotic occlusive lesion in the femoropopliteal segment (> 20 cm). There were two groups: a group of bypass surgery and a group of endovascular intervention. The pseudo-randomization method of propensity score matching was used to align the groups according to various criteria.Results. Primary and secondary patency rates for one- and two-year follow up were comparable between the two groups. A subgroup analysis of above-knee intervention showed that a two-year secondary patency rate was significantly higher in the endovascular intervention group than in the bypass group (90.9% vs. 77.5%, p = 0.048). The subgroup analysis of interventions below the knee joint showed that the patency rates at two years of primary and primary-assisted patency were significantly higher in the endovascular intervention group than in the bypass group with an artificial expanded polytetrafluoroethylene (ePTFE) graft (66.7% versus 42.4%, p = 0.046 and 76.7% versus 45.5%, p = 0.011, respectively). The autovenous graft showed better results for primary patency compared with the endovascular intervention group, but the difference was statistically insignificant (77.2% versus 66.7%, respectively, p = 0.3).Conclusion. The analysis of obtained results suggests that the primary endovascular strategy may be recommended for all prolonged occlusive lesions of the femoropopliteal segment above the knee joint gap. For lesions below the knee joint, the autovenous bypass grafting remains the operation of choice, but in the absence of a suitable autovenous graft, the primary endovascular strategy may also be recommended. Additional large multicenter randomized trials are required to refine these recommendations.
- 7 April 2022
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 37 (1) , 96-107
Open AccessComparative retrospective analysis of the results of open femoral-popliteal bypass grafting and endovascular stenting with an interwoven biomimetic stent in patients with prolonged occlusions of the arteries in the femoropopliteal segment
Introduction. Autovenous graft is considered the gold standard for prolonged occlusive lesions of the arteries in the femoralpopliteal segment. However, the vein is not always anatomically suitable for bypass grafting; it may have been previously used in previous operations, for example, in coronary artery bypass grafting. Open surgery is always more traumatic than endovascular surgery. Conventional nitinol stents show unsatisfactory results in the femoral-popliteal position due to the high percentage of reocclusions associated with their breakage during physiological movements in the leg joints. The modified method of making interwoven nitinol stents allows improving their biomimetic properties and reducing the percentage of breakages and, accordingly, reocclusions.Material and Methods. There was a retrospective analysis of 437 patients with prolonged atherosclerotic occlusive lesion in the femoropopliteal segment (> 20 cm). There were two groups: a group of bypass surgery and a group of endovascular intervention. The pseudo-randomization method of propensity score matching was used to align the groups according to various criteria.Results. Primary and secondary patency rates for one- and two-year follow up were comparable between the two groups. A subgroup analysis of above-knee intervention showed that a two-year secondary patency rate was significantly higher in the endovascular intervention group than in the bypass group (90.9% vs. 77.5%, p = 0.048). The subgroup analysis of interventions below the knee joint showed that the patency rates at two years of primary and primary-assisted patency were significantly higher in the endovascular intervention group than in the bypass group with an artificial expanded polytetrafluoroethylene (ePTFE) graft (66.7% versus 42.4%, p = 0.046 and 76.7% versus 45.5%, p = 0.011, respectively). The autovenous graft showed better results for primary patency compared with the endovascular intervention group, but the difference was statistically insignificant (77.2% versus 66.7%, respectively, p = 0.3).Conclusion. The analysis of obtained results suggests that the primary endovascular strategy may be recommended for all prolonged occlusive lesions of the femoropopliteal segment above the knee joint gap. For lesions below the knee joint, the autovenous bypass grafting remains the operation of choice, but in the absence of a suitable autovenous graft, the primary endovascular strategy may also be recommended. Additional large multicenter randomized trials are required to refine these recommendations.